Company intelligence / Profile preview

Cat Trail Capital

Newton, Massachusetts, United States

Ownership: Private
Employees: ~1
Development stage: Other

Overview

Cat Trail Capital is a private investment and advisory firm founded by Dr. John Maraganore, the former founding CEO of Alnylam Pharmaceuticals. The firm focuses on early-stage life science and biotechnology investments, providing strategic mentorship and capital to the next generation of industry leaders. Through this vehicle, Dr. Maraganore leverages his decades of experience in RNA interference and drug development to support companies advancing innovative therapeutic platforms. The firm is active in the Boston biotech ecosystem and maintains a portfolio of high-growth startups across various modalities. Cat Trail Capital often collaborates with leading venture capital firms to identify and nurture breakthrough scientific innovations.

Industry: Investors

Beyond the preview

Go deeper on Cat Trail Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cat Trail Capital.

Explore the full profile